Position in RVMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$823,154,534
+$139,121,850 QoQ
Shares Held
8,464,314
-1.4% QoQ
Ownership
3.98%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.75629448529439.ToString("F0")%
Shared 0.ToString("F0")%
None 0.24370551470562174.ToString("F0")%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,674,888,413 across 352 Biotechnology names. RVMD ranks #18 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in RVMD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $823,154,534 | 8,464,314 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $684,032,684 | 8,587,981 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $439,058,780 | 9,401,687 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $306,283,518 | 8,325,184 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $266,464,861 | 7,535,771 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $294,898,707 | 6,742,083 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $266,471,746 | 5,875,893 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $218,339,470 | 5,625,856 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $134,294,835 | 4,166,765 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $119,427,819 | 4,164,150 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $19,343,282 | 698,818 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $15,587,545 | 582,712 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $12,967,213 | 598,671 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $10,237,049 | 429,767 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,533,829 | 432,750 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,277,627 | 65,553 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $73,137,678 | 2,867,020 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $153,580,390 | 6,101,724 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $214,519,785 | 7,797,884 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $302,617,377 | 9,534,259 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $496,983,399 | 10,832,245 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $369,750,209 | 9,339,485 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $344,135,842 | 9,888,961 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $249,520,597 | 7,903,725 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $146,009,619 | 6,664,063 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||